CNS vs IVZ
CNS: Cohen & Steers is a specialized global investment manager focused on real assets and income-oriented investment strategies. IVZ: Invesco is a global investment manager offering diverse investment strategies, including specialized ETFs and traditional asset management, to institutional and retail investors.
Side-by-side fundamentals
| Metric | CNS | IVZ | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $70.71 | $30.09 | |
| Market cap | $3.6B | $13.3B | |
| P/E as of 2026-10-08 | 21.71 | n/a | |
| Net margin FY2024, SEC XBRL | n/a | +8.9% | |
| Operating margin FY2025, SEC XBRL | n/a | -10.9% | |
| ROE | +27.3% | +3.6% | CNS higher |
| ROA | +17.5% | +2.0% | CNS higher |
| Debt / equity as of 2026-09-03 | 0.00 | 0.85 | CNS lower |
| Revenue growth (YoY) as of 2026-09-03 | +5.2% | -14.5% | CNS higher |
| Revenue CAGR (3y) SEC XBRL | +4.1% | +1.8% | CNS higher |
| Dividend yield as of 2026-09-03 | +3.6% | +2.9% | CNS higher |
| Dividend streak (yrs) SEC XBRL | 4 | 5 | IVZ higher |
| Beta as of 2026-09-03 | 0.87 | 1.55 | |
| 1-year return as of 2026-10-08 close | +6.7% | +25.4% | IVZ higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.